Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 6 II, 2000, Pages 1194-1201

  Noirey, Nadège ^a   Rougier, Nathalie ^a   André, Claude ^a   Schmitt, Daniel ^b   Vincent, Claude ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Stallergenes SA   (France)

Author keywords

Allergy; Antigen presenting cell; Dendritic cells; Internalization; Langerhans' cells; Macropinocytosis; Primary response; Recombinant Bet v 1; Recombinant Phl p 1

Indexed keywords

POLLEN ANTIGEN;

ALLERGY; ANTIGEN PRESENTATION; ARTICLE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INTERNALIZATION; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; PINOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ALLERGENS; CELL SEPARATION; FETAL BLOOD; HUMANS; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; PINOCYTOSIS; POLLEN; RECOMBINANT PROTEINS; STEM CELLS; T-LYMPHOCYTES;

EID: 0033933006     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106545     Document Type: Article

References (30)

1. Valladeau J, Duvert-Frances V, Dezutter-Dambuyant C, Vincent C, Pin JJ, Massacrier C, et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999;29:2695-704.
2. Caux C. Pathways of development of dendritic cells. Eur J Dermatol 1998;8:375-84
3. Marone G. Asthma: recent advances. Immunol Today 1998;19:5-9
4. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-13.
5. PradalierA, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, et al. Sublingual-swallow immunotherapy (SLIT) with a standardized fivegrass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-28.
6. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493-8.
7. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249-60.
8. Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, André A, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662-72
9. Cooper PJ, Darbyshire J, Nunn AJ, Warner JO. A controlled trial of oral hypo sensitization in pollen asthma and rhinitis in children. Clin Allergy 1984;14:541-50.
10. Taudorf E, Laursen LC, Djurup R, Kappelgaard E, Pedersen CT, Soborg M, et al. Oral administration of grass pollen to hay fever patients. An efficacy study in oral hyposensitization. Allergy 1985;40:321-35.
11. Nelson HS, OppenheimerJ, Vatsia GA, Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92:229-36
12. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNFα cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61
13. Kashihara M, Ueda M, Horiguchi Y, Furukawa F, Hanaoka M, Imamura S. A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol 1986;87:602-7.
14. Spangfort MD, Gajhede M, Osmark P, Poulsen FM, Ipsen H, Larsen JN, et al. Three dimensional structure and epitope of Bet v l. Int Arch Allergy Immunol 1997;! 13:243-5.
15. Wileman T, Boshans RL, Schlesinger P, Stahl P. Monensin inhibits recycling of macrophage mannose-glycoprotein receptors and ligand delivery to lysosomes. Biochem J 1984;220:665-75.
16. Kirk Ziegler H, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 1982;79:175-8.
17. Gaudriault G, Nouel D, Dal Farra C, Beaudet A, Vincent J-P. Receptor induced internalisation of selective peptidic (J, and 5 opioid ligands. J Biol Chem 1997;272:2880-8.
18. Swanson JA, Watts C. Macropinocytosis. Trends Cell Biol 1995;5:424-8.
19. Brossart P, Bevan MJ. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997;90:1594-9.
20. Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill; 1956.
21. Rougier N, Redziniak G, Schmitt D, Vincent C. Evaluation of the capacity of dendritic cells derived from cord blood CD34+ precursors to present haptens to unsensitized autologous T cells in vitro. J Invest Dermatol 1998;110:101-5.
22. Matsuno K, Ezaki T, Kudo S, Uehara Y A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med 1996;183:1865-78.
23. Reis e Sousa C, Stahl PD, Austin JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993;178:509-19.
24. Moll H. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunol Today 1993; 14:383-6.
25. Sallustro F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macro mol ecu les in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182:389-400.
26. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995;375:151-5.
27. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, et al. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J Immunol 1995;154:6285-90
28. Sallusto F, Lanzavechia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J Exp Med 1994;179:1109-18.
29. Rougier N, Redziniak G, Mougin D, Schmitt D, Vincent C. In vitro evaluation of the sensitization potential of weak contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology 2000. In press.
30. Novak N, Haberstok J, Greiger E, Bieber T. Dendritic cells in allergy. Allergy 1999;54:792-803.